Position in GSK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$524,042
-$24,767 QoQ
Shares Held
9,997
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#474
of 1,033 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026May Hill Capital, LLC holds $9,985,779 across 14 Drug Manufacturers - General names. GSK ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,758 | $2,108,598 | |
| 2 | NVS |
Novartis AG
|
9,081 | $1,423,174 | |
| 3 | JNJ |
Johnson & Johnson
|
5,392 | $1,369,406 | |
| 4 | ABBV |
AbbVie Inc.
|
4,097 | $1,030,969 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,298 | $937,793 | |
| 6 | NVO |
Novo Nordisk A S
|
14,529 | $696,520 | |
| 7 | GSK |
GSK plc
This page
|
9,997 | $524,042 | |
| 8 | AZN |
Astrazeneca PLC
|
2,535 | $480,686 |
All Filings in GSK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $524,042 | 9,997 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $548,809 | 9,944 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $401,147 | 8,180 | Shares | Sole | 2026-05-07 | |
| 2025-09-30 | $341,999 | 7,924 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $381,043 | 9,923 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $364,504 | 9,409 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||